• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Phenylpyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Phenylpyrimidines

Recent Advances in the Study of 2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine (CAS: 1523618-07-6) in Chemical Biology and Pharmaceutical Research

2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine (CAS: 1523618-07-6) is a pyrimidine derivative that has recently gained attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. This compound, characterized by its dichloro and methoxyphenyl substituents, serves as a versatile intermediate in the synthesis of biologically active molecules. Recent studies have explored its role in modulating various biological pathways, making it a promising candidate for further investigation.

One of the key areas of interest is the compound's potential as a kinase inhibitor. Kinases play a critical role in cellular signaling and are often implicated in diseases such as cancer and inflammatory disorders. Preliminary studies have demonstrated that 2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine exhibits inhibitory activity against specific kinase targets, suggesting its utility in the development of targeted therapies. Researchers have employed structure-activity relationship (SAR) studies to optimize its potency and selectivity, with promising results in vitro.

In addition to its kinase inhibitory properties, recent research has highlighted the compound's role in the synthesis of novel heterocyclic compounds. Its reactive chloro groups allow for facile functionalization, enabling the creation of diverse chemical libraries for high-throughput screening. This approach has been instrumental in identifying new lead compounds with potential therapeutic applications. For instance, derivatives of 2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine have shown activity against bacterial and fungal pathogens, opening avenues for antimicrobial drug development.

Another noteworthy application of this compound is in the field of medicinal chemistry, where it has been used as a building block for the synthesis of prodrugs. Prodrugs are inactive compounds that undergo biotransformation to release active drugs in vivo, improving pharmacokinetic properties. Researchers have successfully incorporated 2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine into prodrug designs, enhancing drug delivery and reducing side effects in preclinical models.

Despite these advancements, challenges remain in the development of 2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine-based therapeutics. Issues such as solubility, bioavailability, and off-target effects need to be addressed through further optimization and formulation studies. Recent efforts have focused on nanotechnology-based delivery systems to overcome these limitations, with encouraging preliminary results.

In conclusion, 2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine (CAS: 1523618-07-6) represents a valuable scaffold in chemical biology and pharmaceutical research. Its diverse applications, from kinase inhibition to prodrug synthesis, underscore its potential in drug discovery. Ongoing research aims to refine its properties and expand its therapeutic utility, making it a compound of significant interest for future studies.

• 27794-03-2(2-Chloro-5-(4-methoxyphenyl)pyrimidine)
• 651315-80-9(Pyrimidine, 2,4-dichloro-5-(4-methoxyphenyl)-6-phenyl-)
• 146533-38-2(PYRIMIDINE, 4,6-DICHLORO-5-(3,4-DIMETHOXYPHENYL)-)
• 926008-59-5(Pyrimidine, 4,6-dichloro-5-(2,4-dimethoxyphenyl)-)
• 926008-61-9(Pyrimidine, 5-(1,3-benzodioxol-5-yl)-4,6-dichloro-)
• 63558-77-0(2,4-Dichloro-5-phenylpyrimidine)
• 146533-56-4(4,6-Dichloro-5-(4-methoxyphenyl)pyrimidine)
• 1780-39-8(2,4,6-Trichloro-5-phenylpyrimidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)